ECSP992905A - PHARMACEUTICAL COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF MALARIA - Google Patents

PHARMACEUTICAL COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF MALARIA

Info

Publication number
ECSP992905A
ECSP992905A ECSP992905A ECSP992905A EC SP992905 A ECSP992905 A EC SP992905A EC SP992905 A ECSP992905 A EC SP992905A EC SP992905 A ECSP992905 A EC SP992905A
Authority
EC
Ecuador
Prior art keywords
malaria
present
compositions
treatment
compounds
Prior art date
Application number
Other languages
Spanish (es)
Inventor
David Graham Tew
Scott Kevin Thompson
Daniel Frank Beber
Thaddeus Anthony Tomaszek
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP992905 priority Critical patent/ECSP992905A/en
Publication of ECSP992905A publication Critical patent/ECSP992905A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a compuestos y composiciones farmacéuticas que inhiben proteasas, tales como las proteasas de cisteína. En particular, la presente invención se refiere a compuestos y composiciones farmacéuticas que inhiben proteasas de cisteína de la superfamilia de la papaína. Los compuestos y composiciones farmacéuticas de la presente inevnción son útiles para tratar enfermedades, en particular enfermedades parasitarias, que son medidas por tales proteasas. En particular, la presente invención se refiere a un método para tratar la malaria inhibiendo la proteasa de cisteina, falcipaína.The present invention relates to compounds and pharmaceutical compositions that inhibit proteases, such as cysteine proteases. In particular, the present invention relates to compounds and pharmaceutical compositions that inhibit cysteine proteases of the papain superfamily. The compounds and pharmaceutical compositions of the present invention are useful for treating diseases, in particular parasitic diseases, that are measured by such proteases. In particular, the present invention relates to a method of treating malaria by inhibiting the cysteine protease, falcipain.

ECSP992905 1999-04-05 1999-04-05 PHARMACEUTICAL COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF MALARIA ECSP992905A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP992905 ECSP992905A (en) 1999-04-05 1999-04-05 PHARMACEUTICAL COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF MALARIA

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP992905 ECSP992905A (en) 1999-04-05 1999-04-05 PHARMACEUTICAL COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF MALARIA

Publications (1)

Publication Number Publication Date
ECSP992905A true ECSP992905A (en) 1999-08-12

Family

ID=42043894

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP992905 ECSP992905A (en) 1999-04-05 1999-04-05 PHARMACEUTICAL COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF MALARIA

Country Status (1)

Country Link
EC (1) ECSP992905A (en)

Similar Documents

Publication Publication Date Title
UY27234A1 (en) NOVELTY INHIBITORS OF TYROSINE KINASE
UY28215A1 (en) USEFUL KINAZOLINES AS IONIC CHANNEL MODULATORS
ECSP045004A (en) INHIBITORS OF THE 17BETA-HYDROXIESTEROID DEHYDROGENASE TYPE 3 FOR THE TREATMENT OF DEPENDING ANDROGEN DISEASES
UY27872A1 (en) CASPASA INHIBITORS AND USES OF THE SAME.
GT200500007A (en) [1,8] NAFTIRIDIN-2-WAVES AND RELATED COMPOUNDS FOR THE TREATMENT OF CHICHOPHRENIA.
UY27774A1 (en) METALOPROTEIN INHIBITORS OF TRIARIL-OXI-ARIL-ESPIROPIRIMIDINA-2,4,6-TRIONA
ECSP077275A (en) NOVEDOSOS DERIVED FROM HETEROARILSULFAMIDA BENZOFUSIONADOS USEFUL AS ANTICONVULSIVE AGENTS
PA8493701A1 (en) COMPOUNDS TO TREAT OBESITY
CR9465A (en) PHARMACOCINETICALLY IMPROVED COMPOUNDS
CL2004000849A1 (en) COMPOUNDS DERIVED FROM BENZAMIDAS-2-HIDROXI-3-DIAMINOALCANS, USEFUL FOR THE TREATMENT OR PREVENTION OF ALZHEIMER, DOWN SYNDROME, HEREDITARY CEREBRAL HEMORRAGY, DEGENERATIVE DEMENCIES AND OTHERS.
UY28144A1 (en) THERAPEUTIC AGENTS
TR200002940T2 (en) Treatment of diseases caused by parasites by inhibition of cysteine proteases from the papain superfamily
UY28333A1 (en) CASPASA INHIBITORS AND THEIR USES.
UY28098A1 (en) USEFUL ANILINOPIRAZOL DERIVATIVES IN THE TREATMENT OF DIABETES
PA8621901A1 (en) SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES
DK1641803T3 (en) Thienopyrimidine derivatives as potassium channel inhibitors
PA8604201A1 (en) USED 2-AMINO-PYRIDINE DERIVATIVES FOR THE TREATMENT OF DISEASES
UY30220A1 (en) TETRAHYDROPIRIDOTIENOPIRIMIDINA COMPOUNDS AND METHODS FOR USE
MX349188B (en) SNS - 595 AND METHODS TO USE THE SAME.
PA8603001A1 (en) USEFUL COMPOUNDS FOR THE TREATMENT OF DISEASES
CR10974A (en) CARBOXIPEPTIDASE B PLASMATIC INHIBITORS (DIVISIONAL)
EE200400031A (en) A composition of biochemical compounds, its use for inhibiting matrix metalloproteinases, and a pharmaceutical formulation containing it
CO2024017422A2 (en) Compositions and methods for inhibiting the expression of transmembrane serine protease 6 (tmprss6)
BRPI0408299A (en) cathepsin inhibitors s
UY27413A1 (en) OXYCHOCINE AGONISTS